544 related articles for article (PubMed ID: 14508368)
21. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
[TBL] [Abstract][Full Text] [Related]
22. Porcine PD-L1: cloning, characterization, and implications during xenotransplantation.
Jeon DH; Oh K; Oh BC; Nam DH; Kim CH; Park HB; Cho J; Lee JR; Lee DS; Lee G
Xenotransplantation; 2007 May; 14(3):236-42. PubMed ID: 17489864
[TBL] [Abstract][Full Text] [Related]
23. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
[TBL] [Abstract][Full Text] [Related]
24. Immunomodulation by adenoviral-mediated SCD40-Ig gene therapy for mouse allogeneic islet transplantation.
Rehman KK; Bertera S; Trucco M; Gambotto A; Robbins PD
Transplantation; 2007 Aug; 84(3):301-7. PubMed ID: 17700153
[TBL] [Abstract][Full Text] [Related]
25. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
[TBL] [Abstract][Full Text] [Related]
26. Role of NKT cells in allogeneic islet graft survival.
Yang SH; Jin JZ; Lee SH; Park H; Kim CH; Lee DS; Kim S; Chung NH; Kim YS
Clin Immunol; 2007 Sep; 124(3):258-66. PubMed ID: 17662658
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of program death-1 in T cells has mild impact on allograft survival.
Chen L; Hussien Y; Hwang KW; Wang Y; Zhou P; Alegre ML
Transpl Int; 2008 Jan; 21(1):21-9. PubMed ID: 18076633
[TBL] [Abstract][Full Text] [Related]
28. Arsenic trioxide combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed mice.
Xu S; Chen J; Wang F; Kang X; Lan T; Wang F; Li Z; Qi Z; Xing J
Transpl Immunol; 2010 Oct; 24(1):57-63. PubMed ID: 20688163
[TBL] [Abstract][Full Text] [Related]
29. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
30. Distinctive role of donor strain immature dendritic cells in the creation of allograft tolerance.
Kim YS; Yang SH; Kang HG; Seong EY; Lee SH; Gao W; Kenny J; Zheng XX; Strom TB
Int Immunol; 2006 Dec; 18(12):1771-7. PubMed ID: 17068105
[TBL] [Abstract][Full Text] [Related]
31. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
Wong M; La Cava A; Singh RP; Hahn BH
J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
[TBL] [Abstract][Full Text] [Related]
32. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation.
Shepherd DM; Kerkvliet NI
J Immunol; 1999 Sep; 163(5):2470-7. PubMed ID: 10452982
[TBL] [Abstract][Full Text] [Related]
33. Changes in expression of T-cell activation-related molecules and cytokines during tolerance induction in an allogeneic skin transplantation murine model.
Lee EN; Kim EY; Lee J; Lee HJ; Lee KW; Joh JW; Lee SK; Lee DS; Lee HH; Kim SJ
Transplant Proc; 2004 Oct; 36(8):2425-8. PubMed ID: 15561268
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
Wang P; Liu Z; Wu C; Zhu B; Wang Y; Xu H
Transplant Proc; 2008 Oct; 40(8):2729-33. PubMed ID: 18929847
[TBL] [Abstract][Full Text] [Related]
35. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis.
Terrazas LI; Montero D; Terrazas CA; Reyes JL; RodrÃguez-Sosa M
Int J Parasitol; 2005 Nov; 35(13):1349-58. PubMed ID: 16126211
[TBL] [Abstract][Full Text] [Related]
36. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
Qian Y; Boisgerault F; Benichou G; Dana MR
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
[TBL] [Abstract][Full Text] [Related]
37. Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator.
Nakamura Y; Yasunami Y; Satoh M; Hirakawa E; Katsuta H; Ono J; Kamada M; Todo S; Nakayama T; Taniguchi M; Ikeda S
Transplantation; 2003 Apr; 75(8):1115-8. PubMed ID: 12717187
[TBL] [Abstract][Full Text] [Related]
38. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
[TBL] [Abstract][Full Text] [Related]
39. NK cells promote islet allograft tolerance via a perforin-dependent mechanism.
Beilke JN; Kuhl NR; Van Kaer L; Gill RG
Nat Med; 2005 Oct; 11(10):1059-65. PubMed ID: 16155578
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
